Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
126,235,733
-
Total 13F shares
-
362,238
-
Share change
-
+195,210
-
Total reported value
-
$211,908
-
Price per share
-
$0.58
-
Number of holders
-
15
-
Value change
-
+$113,243
-
Number of buys
-
10
-
Number of sells
-
4
Institutional Holders of NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) as of Q1 2025
As of 31 Mar 2025,
NovaBay Pharmaceuticals, Inc. - Common Stock, $0.01 par value (NBY) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
362,238 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, C2C Wealth Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, TWO SIGMA SECURITIES, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Tower Research Capital LLC (TRC), UBS Group AG, SBI Securities Co., Ltd., and BANK OF AMERICA CORP /DE/.
This page lists
15
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.